CIRM Funded Clinical Trials

RPESC-RPE-4W Therapy for dry Age-related Macular Degeneration

Disease Area:

Age-related macular degeneration

Investigator:

Dr. Jeffrey H Stern

Institution:

Luxa Biotechnology

CIRM Grant:

CLIN2-15282 (Active)

Award Value:

$4,009,675.00

Trial Sponsor:

Luxa Biotechnology

Trial Stage:

Phase 1/2

Trial Status:

Launching

Targeted Enrollment:

N/A

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.